To monitor the incidence of Invasive Pneumococcal Disease (IPD) and the impact pneumococcal vaccination (polysaccharide vaccine) for the elderly (over 65s) and those entering the childhood immunisation schedule, eligible for pneumococcal (conjugate) vaccination. Vaccine policy development and evaluation of the impact of policy implementation require baseline information on the epidemiology and strain distribution of pneumococcal disease.
This surveillance system holds patient identifiable information.
By patient identifiable information we mean details such as name, address or
case record number. HPS seeks to limit to a minimum these details and many
systems are anonymised, e.g. do not hold individual names and addresses.
Should you wish details of the patient identifiable information held in this
system, please contact enquiries.